⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Medium-Chain Triglycerides (MCT)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-29 — Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.: C. elegans study: MCT supplementation (or blocking long-chain unsaturated fatty acid synthesis) rescued α-synuclein-driven triglyceride depletion, lipid-droplet loss, and mitochondrial dysfunction; authors note a parallel observation of lower plasma TAGs in Parkinson’s cohorts (human-observational, correlational only). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.
29-sep-2026
novelty 3
per-area 3
strengthens